Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation
Background Triple antithrombotic therapy with warfarin plus two antiplatelet agents is the standard of care after percutaneous coronary intervention (PCI) for patients with atrial fibrillation, but this therapy is associated with a high risk of bleeding. Methods In this multicenter trial, we randoml...
Elmentve itt :
| Szerzők: | |
|---|---|
| Dokumentumtípus: | Cikk |
| Megjelent: |
2017
|
| Sorozat: | NEW ENGLAND JOURNAL OF MEDICINE
377 No. 16 |
| doi: | 10.1056/NEJMoa1708454 |
| mtmt: | 3264495 |
| Online Access: | http://publicatio.bibl.u-szeged.hu/16905 |